Glucose in Dialysis Water in Non-diabetics

Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00439023

Enrollment

Registered

2007-02-22

Start date

2006-05-31

Completion date

2007-05-31

Last updated

2015-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure, Chronic

Keywords

Chronic renal failure, dialysis, hemodialysis,

Brief summary

The purposes are 1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and 2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

Detailed description

Measurement of hormones and blood pressure during dialysis treatment.

Interventions

PROCEDUREdialysis with glucose in dialysis water

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age \> 18 years, 2. Both men and women, 3. Dialysis treatment for at least three months

Exclusion criteria

1. Heart failure, 2. Chronic liver disease, 3. Diabetes mellitus, 4. Malignant disease, 5. Nephrotic syndrome, 6. Lack of compliance, 7 Unwillingness to participate

Design outcomes

Primary

Measure	Time frame
Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones	one week

Secondary

Measure	Time frame
Relationship between changes in blood pressure and changes in hormones during treatment	one week

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026